Skip to main content

Advertisement

Log in

Obstetric and perinatal outcome in HIV positive women receiving HAART in urban Nigeria

  • Materno-fetal Medicine
  • Published:
Archives of Gynecology and Obstetrics Aims and scope Submit manuscript

Abstract

Purpose

To compare the outcome of pregnancy between HIV positive pregnant women on highly active antiretroviral therapy (HAART) and HIV negative controls.

Methods

A prospective matched case–control study.

Results

HIV positive women were significantly more likely to have anaemia in pregnancy [p < 0.001, odds ratio (95% CI) 5.66 (3.0–10.5)], intrauterine growth restriction [p = 0.002, odds ratio (95%CI) 13.82 (1.8–106.7)], preterm labour [p = 0.03, odds ratio (95% CI) 2.89 (1.2–7.0)] and birth weight less than 2,500 g [p < 0.0001, odds ratio (95% CI) 5.43 (2.4–12.0)]. The 5-min apgar score less than 7, admission into neonatal unit, stillbirth and perinatal mortality were comparable between the two groups.

Conclusion

Anaemia in pregnancy, intrauterine growth restriction, preterm labour and birth weight less than 2,500 g are important complications among HIV positive pregnant women. This information is vital for strategic antenatal care planning to improve obstetric and perinatal outcome in these women.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Ekouevi DK, Coffie PA, Becquet R et al (2008) Antiretroviral therapy in pregnant women with advanced HIV disease and pregnancy outcomes in Abidjan, Côte d’Ivoire. AIDS 22(14):1815–1820

    Article  CAS  PubMed  Google Scholar 

  2. Moodley J (2008) Trends in management and outcome of pregnancies in HIV-infected women in the UK and Ireland, 1990–2006. BJOG 115:1074–1075

    Article  CAS  PubMed  Google Scholar 

  3. Carr A, Cooper DA (2000) Adverse effects of antiretroviral therapy. Lancet 356:1423–1430

    Article  CAS  PubMed  Google Scholar 

  4. Federal Ministry of Health (FMOH) (2005) National guidelines for the implementation of prevention of mother-to-child transmission (PMTCT) of HIV/AIDS. Federal Ministry of Health and Social Services, Abuja, Nigeria

    Google Scholar 

  5. Federal Ministry of Health (FMOH) (2006) 2005 Sentinel seropositive surveillance report. National/AIDS/STD Control Programme. Federal Ministry of Health and Social Services, Abuja, Nigeria

    Google Scholar 

  6. Center for Disease Control and Prevention. U.S Public Health Service Task Force recommendations for use of antiretroviral drugs in pregnant HIV-1-infected women for maternal health and interventions to reduce perinatal HIV-1 transmission in the United States. MMWR 2002; 51:1-38

    Google Scholar 

  7. Tuomala RE, Shapiro DE, Mofenson LM et al (2002) Antiretroviral therapy during pregnancy and the risk of adverse outcome. N Engl J Med 346:1863–1870

    Article  PubMed  Google Scholar 

  8. Madeddu G et al (2008) Successful prevention of multidrug resistant HIV mother-to-child transmission with enfuvrtide use in pregnancy. Int J STD AIDS 19(9):644–645

    Article  PubMed  Google Scholar 

  9. Marti C et al (2007) Obstetric and perinatal complications in HIV infected women. Analysis of a cohort of 167 pregnancies. Acta Obstet Gynecol Scand 86(4):409–415

    Article  PubMed  Google Scholar 

  10. O’Brien ME et al (2005) Anaemia is an independent predictor of mortality and immunologic progression of disease among women with HIV in Tanzania. J Acquir Immune Defic Syndr 40(2):219–225

    Article  PubMed  Google Scholar 

  11. Brocklehurst P, French R (1998) The association between maternal HIV infection and perinatal outcome: a systemic review of the literature and meta-analysis. Br J Obstet Gynaecol 105:836–848

    CAS  PubMed  Google Scholar 

  12. Onah HE, Obi SN, Agbata TA, Oguanuo TC (2007) Pregnancy outcome in HIV positive women in Enugu, Nigeria. J Obstet Gynaecol 27(3):271–274

    Article  CAS  PubMed  Google Scholar 

  13. Lionel J (2008) HIV and obstetric complications and fetal outcomes in Vellore, India. Trop Doct 38:144–146

    Article  PubMed  Google Scholar 

  14. Lepage P, Msellati P, van de Perre P, Hitimana D-G, Dabis F (1992) Characteristics of newborns and HIV-1 infection in Rwanda. AIDS 6:882–883

    Article  CAS  PubMed  Google Scholar 

  15. Nair P, Alger L, Hines S, Seiden S, Hebel R, Johnson JP (1993) Maternal and neonatal characteristics associated with HIV infection in infants of seropositive women. J Acquir Immune Defic Syndr 6:298–302

    CAS  PubMed  Google Scholar 

  16. Dreyfuss ML et al (2003) Determinants of low birth weight among HIV infected women in Tanzania. Am J Clin Nutr 77(5):1337–1338

    CAS  Google Scholar 

Download references

Conflict of interest statement

None.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Michael Chudi Ezeanochie.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Olagbuji, B.N., Ezeanochie, M.C., Ande, A.B. et al. Obstetric and perinatal outcome in HIV positive women receiving HAART in urban Nigeria. Arch Gynecol Obstet 281, 991–994 (2010). https://doi.org/10.1007/s00404-009-1186-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00404-009-1186-x

Keywords

Navigation